MARKET

ABCL

ABCL

Abcellera Biologics Inc.
NASDAQ
10.76
+0.24
+2.28%
After Hours: 10.58 -0.18 -1.67% 16:09 01/27 EST
OPEN
10.46
PREV CLOSE
10.52
HIGH
10.85
LOW
10.39
VOLUME
1.25M
TURNOVER
0
52 WEEK HIGH
14.97
52 WEEK LOW
5.42
MARKET CAP
3.08B
P/E (TTM)
13.46
1D
5D
1M
3M
1Y
5Y
Reported Late Thursday, AbCellera Biologics Announces That The U.S. Patent Trial And Appeal Board Upholds Microfluidic Cell Culture Patent; Appeal Board Rejects Third Request By Berkeley Lights For Invalidation Of Abcellera's U.S. Patents
Benzinga · 01/20 05:36
The Latest Analyst Ratings for AbCellera Biologics
Benzinga · 01/06 19:00
SVB Securities Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)
TipRanks · 01/06 16:27
SVB Leerink Maintains Outperform on AbCellera Biologics, Lowers Price Target to $18
Benzinga · 01/06 14:07
--SVB Securities Adjusts Price Target on AbCellera Biologics to $18 From $20, Maintains Outperform Rating
--SVB Securities Adjusts Price Target on AbCellera Biologics to $18 From $20, Maintains Outperform Rating
MT Newswires · 01/06 11:00
Tracking Baker Brothers Portfolio - Q3 2022 Update
Seeking Alpha · 01/06 07:38
AbCellera Biologics: My Updated Current Valuation Estimate
Seeking Alpha · 01/05 07:57
10 Potential 10x Return Stocks For The Next 10 Years
Seeking Alpha · 01/04 16:04
More
About ABCL
AbCellera Biologics Inc. is a technology company that searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. The Company’s full-stack, AI-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. It rebuilds the platform that integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. The Company partners with drug developers of all sizes, from large cap pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

Webull offers kinds of AbCellera Biologics Inc stock information, including NASDAQ:ABCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABCL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABCL stock methods without spending real money on the virtual paper trading platform.